| Literature DB >> 32377977 |
Stacey A Skoretz1,2,3,4, Nicole Anger5, Leslie Wellman6, Osamu Takai5, Allison Empey5.
Abstract
Dysphagia occurs in 11% to 93% of patients following tracheostomy. Despite its benefits, the tracheostomy often co-exists with dysphagia given its anatomical location, the shared pathway of the respiratory and alimentary systems, and the medical complexities necessitating the need for the artificial airway. When tracheostomy weaning commences, it is often debated whether the methods used facilitate swallowing recovery. We conducted a systematic review to determine whether tracheostomy modifications alter swallowing physiology in adults. We searched eight electronic databases, nine grey literature repositories and conducted handsearching. We included studies that reported on oropharyngeal dysphagia as identified by instrumentation in adults with a tracheostomy. We accepted case series (n > 10), prospective or retrospective observational studies, and randomized control trials. We excluded patients with head and neck cancer and/or neurodegenerative disease. Two independent and blinded reviewers rated abstracts and articles for study inclusion. Data abstraction and risk of bias assessment was conducted on included studies. Discrepancies were resolved by consensus. A total of 7079 citations were identified, of which, 639 articles were reviewed, with ten articles meeting our inclusion criteria. The studies were heterogeneous in study design, patient population, and outcome measures. For these reasons, we presented our findings descriptively. All studies were limited by bias risk. This study highlights the limitations of the evidence and therefore the inability to conclude whether tracheostomy modifications alter swallowing physiology.Entities:
Keywords: Deglutition; Deglutition disorders; Dysphagia; Evidence based medicine; Respiratory medicine; Swallowing; Systematic review; Tracheostomy
Year: 2020 PMID: 32377977 PMCID: PMC7202464 DOI: 10.1007/s00455-020-10115-0
Source DB: PubMed Journal: Dysphagia ISSN: 0179-051X Impact factor: 3.438
Fig. 1Study selection process
Study characteristics
| Study | Year | Country | Study design | Age (y) | Patient diagnoses | Tracheostomy manipulation | Swallow outcomes | ||
|---|---|---|---|---|---|---|---|---|---|
| Instrumentation | Measures | ||||||||
| Amathieu et al. [ | 2012 | France | Case series | 12 | 37.0 | Traumaa | Cuffb | EMG and accelerometry | Quantitative |
| Davis et al. [ | 2002 | USA | Case series | 12 | 60.0 | Medical, respiratoryc | Cuffd | VFSS | Impairment |
| Elpern et al. [ | 2000 | USA | Case series | 15 | 60.1 (14.4) | Cardiothoracic, medical, neurogenic, trauma, respiratorye | Valvef | VFSS | Impairment |
| Donzelli et al. [ | 2006 | USA | TCase series | 40 | 62.8 (12.0) | Medical, neurogenic, respiratoryg | Occlusionh | FEES | Impairment |
| Leder [ | 1999 | USA | Case series | 20‡ | 68.0 (13.0) | Cardiothoracic, medical, neurogenic, surgical, trauma, respiratoryi | Valvef | FEES | Impairment |
| Leder et al. [ | 2001 | USA | Case series | 11 | 64.3 (15.4) | Medical, respiratoryj | Occlusionk | Manometry | Quantitative |
| Leder et al. [ | 1996 | USA | Case series | 19 | 61.0 (21.0) | Cardiothoracic, medical, neurogenic, respiratoryl | Occlusionm | VFSS | Impairment |
| Ledl and Ullrich [ | 2017 | Germany | Case series | 20 | 61.5 (12.8) | Neurogenicn | Occlusionm | FEES and manometry | Impairment; quantitative |
| Ohmae et al. [ | 2006 | Japan | Case series | 16 | 67.3 (13.0) | Respiratory, medical, cardiothoracico | Valvef | FEES and VFSS | Impairment; quantitative |
| Suiter et al. [ | 2003 | USA | Case series | 18 | 19–80 (range) | Cardiothoracic, neurogenic, respiratoryp | Cuff, valveq | VFSS | Impairment; quantitative |
ARDS acute respiratory distress syndrome; CABG coronary artery bypass graft surgery; CHF congestive heart failure; COPD chronic obstructive pulmonary disease; CVA cerebral vascular accident; EMG electromyography; FEES fiberoptic endoscopic evaluation of swallowing; MVA motor vehicle accident; N patients who meet inclusion criteria for this review; PNA pneumonia; SD standard deviation; VFSS videofluoroscopic swallowing study; y year
aThoracic/abdominal. bCuff pressure variations: 5, 10, 15, 20, 25, 30, 40, 50, and 60 cm H2O. cMulti-organ failure, sepsis, ARDS, pneumonia. dInflation/deflation comparison. eMultiple trauma, CABG, CVA, CHF, PNA, lung cancer, smoke inhalation, COPD. f ± one-way speaking valve. gHeart failure, CVA, traumatic brain injury, spinal cord injury, respiratory failure. hDigital occlusion, one-way speaking valve, cap. iThoracic aortic aneurysm, post-operative CVA, adult-onset diabetes, perforated duodenal ulcer repair, MVA, cancer, CVA, nephrectomy, hemicolectomy, esophagectomy, bowel resection, incarcerated hernia repair, ARDS, Legionnaire’s disease, respiratory failure. jCHF, subglottic stenosis, abdominal aortic aneurysm, cardiac arrest, PNA, COPD, ARDS. k ± digital occlusion. lCoronary artery disease, colon cancer, necrotic left lung, human immunodeficiency virus, MVA, liver cirrhosis, cancer, assault/multiple facial and non-facial trauma, quadriplegia, CVA, PNA, ARDS, COPD, cardio-pulmonary disease. m ± occlusion (method unspecified). nCVA. oRespiratory failure, pharyngeal edema, heart failure. pCABG, abdominal aortic aneurysm repair, closed head injury, COPD, ARDS. qCuff inflation vs. deflation, cuff inflation vs. one-way speaking valve, cuff deflation vs. one-way speaking valve
*Unless otherwise stated
‡13 patients did not receive FEES following speaking valve removal therefore this FEES data not included herein
Risk of bias across studies
| Study | Sequence generation | Allocation concealment | Patient sampling description | Inclusion/exclusion criteria | Assessor blinding | Attrition justified | All outcomes addressed | Selective outcome reporting | Outcomes operationally defined | Tracheostomy conditions operationally defined | Consistent assessment for enrollees | Baseline measures |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amathieu et al. [ | N/A | N/A | No | Yes | Unclear | Yes | Yes | No | Yes | Yes | Yes | Yes |
| Davis et al. [ | N/A | N/A | Yes | Yes | Yes | Yes | Yes | No | Yes | No | Yes | No |
| Donzelli et al. [ | N/A | N/A | Yes | No | Unclear | Yes | Yes | No | Yes | No | Yes | No |
| Elpern et al. [ | N/A | N/A | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | N/A |
| Leder [ | N/A | N/A | No | No | Unclear | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Leder et al. [ | N/A | N/A | No | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes |
| Leder et al. [ | N/A | N/A | No | Yes | Unclear | Yes | Yes | No | Yes | Yes | Yes | Yes |
| Ledl and Ullrich [ | N/A | N/A | Yes | Yes | Unclear | Yes | Yes | No | Yes | Yes | Yes | No |
| Ohmae et al. [ | N/A | N/A | No | Yes | Unclear | Yes | Yes | No | Yes | Yes | No | No |
| Suiter et al. [ | N/A | N/A | No | No | Unclear | Yes | Yes | Yes | Yes | Yes | Yes | No |
N/A not applicable
Swallowing impairment and scale type according to tracheostomy modifications
| Study | Airway | Outcomes | ||||
|---|---|---|---|---|---|---|
| TT duration | TT modification | Condition comparison | Impairment | Rating scale | Functional improvement‡ | |
| Davis et al. [ | NR | NR | Infl vs. defl | Asp | 5-pt scalea | Yb |
| Suiter et al. [ | 5–29 | Worn at least once | Infl vs. defl | PA | PAS | N |
| Res | 3-pt scalec | N | ||||
| Suiter et al. [ | 5–29 | Worn at least once | Infl vs. + SV | PA | PAS | Y |
| Res | 3-pt scalec | Nd | ||||
| Defl/cuffless vs. + SV | PA | PAS | Ye | |||
| Res | 3-pt scalec | N | ||||
| Elpern et al. [ | 13–58 | Variablef | − SV vs. + SV | Asp | ± | Yg |
| Pen | ||||||
| Leder [ | 4–49 | 3.9 (1.4) | − SV vs. + SV | Asp | ± | Yh |
| Ohmae et al. [ | 30–90+ | NR | − SV vs. + SV | Asp | ± | N |
| Pen | ± | Y | ||||
| Resi | 3-pt scale | Y | ||||
| Resj | 3-pt scale | N | ||||
| Donzelli et al. [ | NR | NR | Digital occl vs. + SV vs. capped | Asp | ± | Yk |
| Secretion level | 5-pt scalel | Y | ||||
| Leder et al. [ | 8–546 | NR | Unoccl vs. occl | Asp | ± | Nm |
| Ledl and Ullrich [ | 58.0 (mean); 34.1 (SD) | Cuff deflation: 8.0 (7.0) hours/d Capped: 4.9 (5.3) hours/d | Unoccl vs. occl | PA | PAS | Y |
Asp aspiration, d days, defl cuff deflation, infl cuff inflation, N no, NR not reported, NS non-significant findings reported, but no p-value provided, occl occlusion, PA penetration and aspiration, PAS Penetration–aspiration Scale [49], Pen penetration, pt point, Res residue, SD standard deviation, SV speaking valve, TT tracheostomy tube, unoccl unocclusion, y year, Y yes
aGrading Scale: 0 = no aspiration, 1 = aspiration of less than 10% accompanied by cough, choking, or distress, 2 = aspiration of less than 10% without cough, 3 = aspiration of more than 10% with cough, 4 = aspiration of more than 10% without cough. bCuff status and bolus type were significant aspiration predictors. c3-point scale: 0 = no residue, 1 = coating, 2 = pooling. dResidue was greater with + SV. eFor thin liquid boluses only. fTwelve subjects had intermittent use of Passy-Muir speaking valve, ranging from 2–6 weeks. gReduced aspiration with PMV on, p = 0.016. hNo aspiration after initial SV placement in 7/20 previously aspirating patients, not statistically tested. iLaryngeal residue. jPharyngeal residue. kAspiration rates reduced however occlusion type and aspiration rate relation not statistically significant. lMarianjoy 5-point secretion scale. mNot statistically tested
*Unless otherwise specified, **data meeting inclusion criteria, ‡comparison statistically significant unless otherwise specified, + presence, − absence
Quantitative measures according to tracheostomy modifications
| Study | Airway | Outcomes | ||||
|---|---|---|---|---|---|---|
| TT duration | TT condition | Study comparison | Parameter | Measurement | Functional improvement** | |
| Amathieu et al. [ | NR | NR | Infl vs. defl | Submental muscle activity | EMGp | Y |
| Laryngeal acceleration | ALA | Y | ||||
| Swallow latency time | ms | Y | ||||
| Suiter et al. [ | 5- to- 29 | Worn at least once | Infl vs. defl | Swallow durationsa | ms | Y |
| Pharyngeal transit duration | Nb | |||||
| Anterior hyoid excursion duration | Yb | |||||
| Cricopharyngeal opening duration | Yc | |||||
| Laryngeal elevation | mm | N | ||||
| Anterior hyoid excursion | Y | |||||
| Suiter et al. [ | 5-to-29 | Worn at least once | Infl vs. + SV | Swallow durationd | ms | N |
| Laryngeal elevation | mm | N | ||||
| Anterior hyoid excursion | N | |||||
| Defl/cuffless vs. + SV | Swallow durationd | ms | N | |||
| Laryngeal elevation | mm | N | ||||
| Anterior hyoid excursion | N | |||||
| Ohmae et al. [ | 30–90+ | NR | -SV vs. + SV | Laryngeal elevation | NR | N |
| Swallow reflex | NR | N | ||||
| Leder et al. [ | 6d–5.5y | NR | Unoccl vs. occl | Pharyngeal pressuree | mmHg | N |
| UES pressuree | N | |||||
| Ledl et al. [ | 58.0 (mean); 34.1 (SD) | Cuff deflation: 8.0 (7.0) hours/d Capped: 4.9 (5.3) hours/d | Unoccl vs. occl | Oropharyngeal pressure | mmHg | N |
| Hypopharyngeal pressure | N | |||||
| UES relaxation | N | |||||
| Oropharyngeal pressure duration | sec | N | ||||
| Hypopharyngeal pressure duration | N | |||||
| UES relaxation duration | N | |||||
ALA amplitude of laryngeal acceleration, defl cuff deflation, EMGp peak electromyographic activity, infl cuff inflation, mm millimeters, mmHg millimeter of mercury, ms milliseconds, N no, NR not reported, NS non-significant findings reported and no p-value provided, occl occlusion, sec seconds, SV speaking valve, UES upper esophageal sphincter, unoccl unocclusion, y year, Y yes
aSwallow duration measures (oral transit, stage transition, and total swallow) not reported individually. bLonger duration with deflated condition. cShorter duration with deflated condition. dMeans and p-values for individual swallow duration measures (oral transition, stage transition, pharyngeal transit, maximum hyoid, maximum anterior excursion, cricopharyngeal opening, and total swallow) were not reported. eOutcomes pertain to all patients (n = 11), non-aspirating patients (n = 7), and aspirating patients (n = 4)
*Unless otherwise specified; **comparison statistically significant unless otherwise stated; > greater than; + , presence
Fig. 2Swallowing impairment according to tracheostomy tube modifications. DO digital occlusion, Infl cuff inflation, NR not reported, NT not tested statistically, SV speaking valve, Unoccl unoccluded, Occl occluded; ( +) = with; ( −) = without
Fig. 3Penetration–aspiration scores according to tracheostomy tube modifications. ( +) Inflation vs. ( +) SV condition significant (p = 0.01). Infl cuff inflation, NR not reported, SV speaking valve, ( +) = with, ( −) = without
Fig. 4Quantitative measures according to tracheostomy tube occlusion. mmHG millimeter of mercury, NS not significant, UES upper esophageal sphincter